reprexain hydrocodone bitartrate and ibuprofen tablet film coated
INDICATIONS AND USAGE Carefully consider the potential benefits and risks of REPREXAIN™ and other treatment options before deciding to use REPREXAIN™. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see WARNINGS ). REPREXAIN™ tablets are indicated for the short-term (generally less than 10 days) management of acute pain. REPREXAIN™ is not indicated for the treatment of such conditions as osteoarthritis or rheumatoid arthritis.
quinnova pharmaceuticals, llc
OVAL WHITE IP 116
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED REPREXAIN™ (hydrocodone bitartrate and ibuprofen tablets), 2.5 mg/200 mg, are supplied as white, capsule-shaped, film-coated tablets, debossed “IP 116” on obverse and plain on reverse. They are available as follows: Bottles of 100 NDC 23710-900-01 REPREXAIN™ (hydrocodone bitartrate and ibuprofen tablets), 5 mg/200 mg, are supplied as white, oval-shaped, film-coated tablets, debossed “IP 146” on obverse and plain on reverse. They are available as follows: Bottles of 100 NDC 23710-901-01 REPREXAIN™ (hydrocodone bitartrate and ibuprofen tablets), 10 mg/200 mg, are supplied as yellow, round-shaped, film-coated tablets, debossed “IP 117” on obverse and plain on reverse. They are available as follows: Bottles of 100 NDC 23710-902-01 Storage Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container. A Schedule CS-III Controlled Substance.
More pills like OVAL IP 116